Research Article

Dermatomycoses in Pakistan; an urgent need for National Surveillance Programs

Sara Rizwan Uppal, Aftab Ahmad Khan, Umar Saeed*, Zahra Zahid Piracha and Zuhaib Ali

Published: 10 May, 2022 | Volume 6 - Issue 1 | Pages: 014-016

Despite the rising burden of fungal infections across the globe, the World Health Organization's efforts remained questionable in fungal infection-related projects. Most of the developing countries consequently lost focus on the need for assessment and establishment of national surveillance set up or advanced technology hubs against mycological infections. The current study aimed to the determination of the local burden of cutaneous fungal infections in 2019-2021. Among 497 suspected fungal cultures, 22.5% depicted fungal growth. Among males, the prevalence of dermatomycosis was 0.75 times higher than in females. Penicillium species followed by Epidermophyton and Candida species were common among subjects of < 30 years of age. The Aspergillus spp, Penicillium spp, mucormycosis agents, and Candida albicans infections were more common among subjects 30 to 60 years of age. Aspergillus species were more commonly observed among patients > 60 of age. 22.2% of the fungal infections were Penicillium species, 9% of the infections were Aspergillus species, followed by 4.4% of Epidermophyton, mucormycosis, Candida species, and Candida albicans respectively. There is an urgent need for the establishment of national policy for the prevention of fungal disease.

Read Full Article HTML DOI: 10.29328/journal.adr.1001021 Cite this Article Read Full Article PDF


  1. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008 Sep;51 Suppl 4:2-15. doi: 10.1111/j.1439-0507.2008.01606.x. Erratum in: Mycoses. 2009 Jan;52(1):95. PMID: 18783559.
  2. Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2017 Oct 18;3(4):57. doi: 10.3390/jof3040057. PMID: 29371573; PMCID: PMC5753159.
  3. Stop neglecting fungi. Nat Microbiol. 2017 Jul 25;2:17120. doi: 10.1038/nmicrobiol.2017.120. Erratum in: Nat Microbiol. 2017 Jul 31;2:17123. PMID: 28741610.
  4. Life-threatening fungal infections affect 3.2 million Pakistanis, moot told. The News, Tuesday, Dec 05, 2017. Available online [https://www.thenews.com.pk/print/252169-life-threatening-fungal-infections-affect-3-2-million-pakistanis-moot-told].
  5. Saeed U, Uppal SR, Piracha ZZ, Rasheed A, Aftab Z, Zaheer H, Uppal R. Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy. Virol J. 2021 Feb 13;18(1):34. doi: 10.1186/s12985-021-01505-3. PMID: 33581714; PMCID: PMC7881305.
  6. Saeed U, Uppal SR, Piracha ZZ, Uppal R. Azithromycin Treatment for SARS-CoV-2-related COVID-19 Pandemic Could Worsen Extensively Drug Resistant (XDR) Typhoid: A Risk of Losing the Last Bullet Against Salmonella enterica Serovar Typhi. Jundishapur J Microbiol. 2021 January; 14(1):e113874.
  7. Marghoob M, Saeed U, Piracha ZZ, Shafiq H, Fatima N, Sarfraz N, Farooq N, Uppal R. SARS-COV2 Infection and Incidence of Mucormycosis. Archives of Clinical and Biomedical Research 6 (2022): 41-49.
  8. Piracha ZZ, Saeed U, Sarfraz R, Asif U, Waheed Y, Raheem A, Tahir M, Kiran S, Pervaiz I, Uppal R. Impact of SARS-CoV-2 on Onset of Diabetes and Associated Complications. Archives of Clinical and Biomedical Research 6 (2022): 217-227.
  9. Saeed U, Zahid Piracha Z, Uppal R, Uppal R. SARS-CoV-2-Associated CRP, DD, FER, HBA1c, IL6, LDH, PBNP, and PCT Biomarkers and High-Resolution Computed Tomography During the First Three Waves of COVID-19 in Pakistan (2019-2021). Jundishapur J Microbiol. 2022;15(1):e119590.
  10. Saeed U, Piracha ZZ, Ashraf H, Tasneem S, Uppal SR, Islam T, Fatima M, Abid A, Uppal R, Uppal R. Effectivity Analysis of COVID-19 Vaccines Against Emerging Variants of SARS-CoV-2. Archives of Clinical and Biomedical Research 6 (2022): 209-216.
  11. Piracha ZZ, Saeed U, Sarfraz R, Asif U, Waheed Y, Raheem A, Tahir M, Kiran S, Pervaiz I, Uppal R. Impact of SARS-CoV-2 on Onset of Diabetes and Associated Complications. Archives of Clinical and Biomedical Research 6 (2022): 217-22.
  12. Azhar A, Saeed U, Piracha ZZ, Amjad A, Ahmed A, et al. SARS-CoV-2 related HIV, HBV, RSV, VZV, Enteric viruses, Infl uenza, DENV, S. aureus and TB co-infections. Arch Pathol Clin Res. 2021; 5: 020-033.
  13. Amjad Q, Saeed U, Piracha ZZ, Kanwal K, Munir M, et al. Contemplating SARS-CoV-2 infectivity with respect to ABO blood groups. Int J Clin Virol. 2021; 5: 082-086.


Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More